Pediatric COVID-19 symptoms differed by variant
The Omicron variant caused the most symptoms in pediatric patients. However, there were no differences in adverse outcomes by COVID-19 variant.
COVID-19 vaccine effective against hospitalization from Omicron variant
In a recent study, children aged 5 to 11 years were less likely to be hospitalized with the Omicron strand if they received vaccination against COVID-19.
Penicillin allergy documentation uninformative in allergy tabs
In a recent study, penicillin allergy documentation was uninformative in allergy tabs, and children were not often referred to allergists.
Covis withdraws Makena from the market
Covis, the manufacturer of the controversial preterm birth prevention drug Makena, has announced it will voluntarily withdraw the drug from the market after recommendations from the Center for Drug Evaluation and Research.
E-cigarette use more common among sexual minority youth
In a recent study, the prevalence of e-cigarette use was greater among sexual minority youth than heterosexual or questioning youth.
Poor rate of outpatient care following mental health ED visit
In a recent study, a poor connection was reported between mental health emergency department discharge and follow-ups through outpatient care.
FDA accepts sNDA for empagliflozin in children with type 2 diabetes
A supplemental New Drug Application for empagliflozin (Jardiance; Boehringer Ingelheim and Eli Lilly and Company) in pediatric patients with type 2 diabetes has been accepted by the FDA.
Childhood respiratory infection linked to adult mortality
In a recent study, the risk of death from respiratory diseases during adulthood almost doubled in individuals who experienced a lower respiratory tract infection at a young age.
FDA accepts NDA for berdazimer gel to treat molluscum contagiosum
Following positive results from a phase 3 clinical trial, the FDA has accepted a New Drug Application for berdazimer gel, 10.3% (Novan) for treating patients with molluscum contagiosum.
Which COVID-19 variant caused the most severe disease in children?
Children were hospitalized the most during the Omicron variant, but disease outcomes were the least severe during this variant period.
Dupilumab sNDA accepted for chronic spontaneous urticaria in adolescents
A supplemental Biologics License Application has been accepted by the FDA for treating adolescents and adults with chronic spontaneous urticaria.
AAP: Reducing crowding in emergency departments
In a new policy statement, the American Academy of Pediatrics has provided guidelines on reducing crowding in emergency departments.
Violence encounters increase suicidal ideation among adolescents
In a recent study, the rate of suicidal ideation was 1.7 times greater among adolescents with depression who had experienced a violent encounter in the past year.
Mustafa Özçam, PhD: investigating gut microbiome in children with peanut allergy
Data from AAAAI 2023 suggests that gut microbial composition, function, and metabolic activity are implicated in the efficacy of peanut oral immunotherapy in children with peanut allergy.
Associations of preterm birth and postnatal growth with brain maturation
In a recent study, worse neurodevelopmental outcomes were seen in children born preterm and with postnatal growth failure.
FDA approves velmanase alfa-tycv for alpha-mannosidosis
Velmanase alfa-tycv (Lamzede, Chiesi Global Rare Diseases) has received approval by the FDA for treating alpha-mannosidosis in adult and pediatric patients.
How technology can ease provider burnout and improve patients’ health care experience
From AI-powered symptom checking to virtual intake tools, recent technological advances hold promise for enhancing care delivery.
Tumor necrosis factor inhibitors safely, effectively treat patients with juvenile idiopathic arthritis
Results of a recent review showed that adalimumab, etanercept, golimumab, and infliximab are effective and well-tolerated treatments options for patients with juvenile idiopathic arthritis.
FDA approves omaveloxolone for pediatric use
Omaveloxolone (SKYCLARYS, Reata Pharmaceuticals) has received FDA approval for treating Friedreich’s ataxia in patients aged 16 years and older.
Effectiveness of monovalent mRNA vaccines against COVID-19 in young children
In a recent report from the CDC, monovalent vaccines from Moderna and Pfizer have shown vaccine effectiveness in children aged 3 to 5 years in at least the first 4 months after vaccination.
FDA accepts application for VP-102 for treating molluscum contagiosum
A new drug application for VP-102 for treating molluscum contagiosum has been accepted by the FDA.
Suicide rates among youths during COVID-19
In a recent study, rates of suicide during the COVID-19 pandemic were higher among youths aged 5 to 24 years than expected based on trends prior to the pandemic.
Five common allergens causing contact dermatitis identified in pediatric population
In data presented at the AAAAI annual conference, 5 common contact dermatitis-causing allergens were identified, emphasizing the importance of patch testing.
Ultrasound radiomics for predicting extrathyroidal extension in children
In a recent study, ultrasound radiomics showed effective predictive ability for extrathyroidal extension (ETE) in pediatric papillary thyroid cancer (PTC).
Sadness and violence among teenage girls
A recent report from the CDC detailed increasing rates of sadness and violence among US teenage girls.
Fruit, vegetable, and sugary drink consumption in young children
A recent report from the Centers for Disease Control and Prevention outlined rates of fruit, vegetable, and sugary drink intake among young children by state.
COVID-19 vaccination during pregnancy reduces risk of infant infection
A booster dose of mRNA COVID-19 vaccination during pregnancy increases protection of infants from infection and related hospitalization.
How parents manage fever in children
A recent poll from the C.S. Mott Children’s Hospital National Poll on Children’s Health showed how parents respond to potential fever in their children.
Infants with acute ROP remain at risk of vision-threatening outcomes in later life
Investigators stress the need for timely surgical intervention to ensure favorable visual outcomes in patients with severe complications, including retinal detachment and vitreous hemorrhage.
The latest FDA approvals for children’s medications
Read the latest medications for pediatric patients approved by the US Food and Drug Administration.